Publisher： Bentham Science Publishers
E-ISSN： 1996-3181|11|5|528-544
ISSN： 1871-5273
Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.11, Iss.5, 2012-01, pp. : 528-544
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Natalizumab: multiple benefits in multiple sclerosis
Inpharma, Vol. 1, Iss. 1487, 2005-01 ,pp. :
Role of Cannabinoids in Multiple Sclerosis
CNS Drugs, Vol. 25, Iss. 3, 2011-03 ,pp. :
Management of Children with Multiple Sclerosis
By Yeh E. Ann
Pediatric Drugs, Vol. 14, Iss. 3, 2012-06 ,pp. :
Multiple Sclerosis in the Elderly Patient
Drugs & Aging, Vol. 27, Iss. 4, 2010-04 ,pp. :